- Home
- IMUX vs STSS Comparison
IMUX vs STSS Comparison
Compare IMUX & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- STSS
- Stock Information
- Founded
- IMUX 2016
- STSS 2017
- Country
- IMUX United States
- STSS United States
- Employees
- IMUX N/A
- STSS N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- IMUX Health Care
- STSS Health Care
- Exchange
- IMUX Nasdaq
- STSS Nasdaq
- Market Cap
- IMUX 92.2M
- STSS 103.6M
- IPO Year
- IMUX N/A
- STSS 2022
- Fundamental
- Price
- IMUX $0.76
- STSS $3.16
- Analyst Decision
- IMUX Strong Buy
- STSS
- Analyst Count
- IMUX 5
- STSS 0
- Target Price
- IMUX $6.00
- STSS N/A
- AVG Volume (30 Days)
- IMUX 1.3M
- STSS 152.8K
- Earning Date
- IMUX 11-13-2025
- STSS 11-17-2025
- Dividend Yield
- IMUX N/A
- STSS N/A
- EPS Growth
- IMUX N/A
- STSS N/A
- EPS
- IMUX N/A
- STSS N/A
- Revenue
- IMUX N/A
- STSS $2,511,767.00
- Revenue This Year
- IMUX N/A
- STSS N/A
- Revenue Next Year
- IMUX N/A
- STSS N/A
- P/E Ratio
- IMUX N/A
- STSS N/A
- Revenue Growth
- IMUX N/A
- STSS N/A
- 52 Week Low
- IMUX $0.56
- STSS $2.82
- 52 Week High
- IMUX $1.42
- STSS $1,248.28
- Technical
- Relative Strength Index (RSI)
- IMUX 47.49
- STSS 31.44
- Support Level
- IMUX $0.67
- STSS $3.63
- Resistance Level
- IMUX $0.79
- STSS $4.04
- Average True Range (ATR)
- IMUX 0.05
- STSS 0.34
- MACD
- IMUX 0.00
- STSS -0.03
- Stochastic Oscillator
- IMUX 64.28
- STSS 17.23
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.